ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

Budget Year

November 12, 2010

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994

NCI Using Three Methods To Encourage Grants In Programs

August 25, 1978

House Appropriations by Institute

July 8, 1994

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

Budget Would Support 1,211 More Grants

February 7, 2003